PGV-001-based Personalized Multi-peptide Vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PGV-001-based Personalized Multi-peptide Vaccine, covering 2026-01-07 to 2026-01-07. Get the full timeline:
Most recent: Clinical Trial Update: The Safety and Tolerability of PGV001-based Personalized Multi-peptide Vaccines in the Adjuvant Setting. [Phase 1]